Designates Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.) Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease. Recognizes the ongoing courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials. Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals.
Get AI-generated questions to help you understand this bill better
Timeline
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6234; text: CR S6231)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S6234; text: CR S6231)
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6234; text: CR S6231)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S6234; text: CR S6231)
Cardiovascular and respiratory healthCommemorative events and holidaysCongressional tributesHealth personnelMedical researchSocial work, volunteer service, charitable organizations
A resolution designating September 2017 as "Pulmonary Fibrosis Awareness Month".
USA115th CongressSRES-276| Senate
| Updated: 9/28/2017
Designates Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.) Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease. Recognizes the ongoing courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials. Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals.
Get AI-generated questions to help you understand this bill better
Timeline
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6234; text: CR S6231)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S6234; text: CR S6231)
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6234; text: CR S6231)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S6234; text: CR S6231)